Beijing Mesochem Technology Co,Ltd is a science and technology enterprise which specializes in R&D and manufacturing pharmaceutical raw materials and intermediates. The main products are Olaparib,Enzalutamide,Lenvatinib mesylate,Capmatinib hydrochloride ,Dabrafenib mesylate, Momelotinib hydrochloride,Finerenone,Aprocitentan,Resmetirom,Dotinurad,Prucalopride succinate,Gefapixant Citrate,Etrasimod ,Fezolinetant,Repotrectinib,and so on.
more >
Year of Establishment:
2008
Total Assets(USD):
500,000 to 99,999,999
Total Number of Staff:
50-100
Main Competitive Advantages:
Experienced R&D Staff,Delivery Term,Production Capacity,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Reputation,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
All,Trading Company,Manufacturer
R&D capacity:
Own Brand
Annual Turnover(USD):
500,000 to 99,999,999
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Asia,Middle East,Africa
Other Competitive Advantages:
Patents and Copyrights: